RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

Thanks to Haysaw and you for bringing these docs to our attention.

Who is liable for all this debt?

Is expanding the BOD consistent with a strategy to conduct a fire sale? Based on the actions of the new management, does anybody have any ideas about where they are planning on taking this IP?

I remain banjaxed by the fact that nothing has happened with the RD indication. Is nobody in pharma paying attention? RD is in all likelihood the biggest public health risk associated with taking medication, and the number of fatalities keeps rising. Incorporating an ampakine into their formulation would dramatically lower the risk. Why is this going unnoticed? A pharma that brings out a safer pain-management medication would have a mega-blockbuster on its hands. What gives?

If I were running the outfit, I would approach VCs with the simple pitch to secure funds to bring ampakines into the clinic for the most easily accessible indication, probably post operative RD. If/when it gains approval for that indication, move towards a partnership that incorporates ampakines in one of the many pain management formulations that are being used by millions. That's a big payday, and it's not that hard. Efficacy is established, and the market is huge.